Author

Phil Reynolds

Institutions: Clatterbridge Cancer Centre NHS Foundation Trust, Clatterbridge Hospital

Observed institutions: University of Liverpool, Clatterbridge Cancer Centre NHS Foundation Trust, Clatterbridge Hospital

ORCID: 0000-0003-2407-797X

Observed ORCID: 0000-0003-2407-797X

OpenAlex ID: A5019314035

UroLift implants as surrogate fiducial markers for cone-beam CT-based prostate image-guided radiotherapy

2023 · Ahmed Al-Balushi, Michelle Cain, et al. · Journal of Radiotherapy in Practice · 1

Machine learning vs logistic regression to predict late gastrointestinal toxicity after prostate cancer radiotherapy

2026 · Rhiju Chatterjee, Helen Mayles, et al. · The Royal College of Radiologists Open

Vacuum erectile devices for managing erectile dysfunction for those receiving radical prostate radiotherapy and androgen deprivation therapy: a user evaluation

2025 · Isabel Wilson, Phil Reynolds, et al. · Journal of Radiotherapy in Practice

1991: Real world risk factors for gastrointestinal toxicity following radical prostate cancer EBRT

2024 · Rhiju Chatterjee, Phil Reynolds, et al. · Radiotherapy and Oncology

Works count: 4

Citation count: 1

H-index: 1

I10-index: